OBJECTIVE: To investigate the levels of cytokines related to T-helper (Th) 17 cells in serum and signal transducers in the psoriatic lesions of patients with psoriasis vulgaris of blood-heat syndrome (BHS) and blood-stasis syndrome (BSS). METHODS: Sixty patients with psoriasis vulgaris were divided into the BHS and BSS groups according to the syndrome differentiation of Chinese medicine (CM). Ten healthy subjects were considered as the control group. Cytokine levels of interleukin (IL)-17, IL-23 and IL-6 in serum were determined by enzyme-linked immunosorbent assay. Expression levels of signal transducer and activator of transcription 3 (STAT3), p38-mitogen-activated protein kinase (MAPK) and STAT6 in the psoriatic lesions were determined using immunohistochemistry (IHC), Western blot, and real-time quantitative reverse transcription polymerase chain reaction, respectively. RESULTS: Production of IL-17, IL-23 and IL-6 in the BHS group and BSS group were significantly increased compared with those in the control group (P<0.05). Levels of IL-17 and IL-23 in the BHS group were higher than those in the BSS group (P<0.05). Compared with the control group, IHC positive expressions and protein expressions of STAT3 and p38-MAPK, and the STAT3 mRNA expressions in the BHS and BSS groups were significantly higher (P<0.05 or P<0.01). The protein expression of STAT3 in the BHS group was significantly higher than that in the BSS group (P<0.05). CONCLUSIONS: Cytokines in serum and signal transducers in the psoriatic lesions alter with various CM syndromes of psoriasis. The results provide scientific basis for the treatment based on syndrome differentiation of CM in treating psoriasis vulgaris.
OBJECTIVE: To investigate the levels of cytokines related to T-helper (Th) 17 cells in serum and signal transducers in the psoriatic lesions of patients with psoriasis vulgaris of blood-heat syndrome (BHS) and blood-stasis syndrome (BSS). METHODS: Sixty patients with psoriasis vulgaris were divided into the BHS and BSS groups according to the syndrome differentiation of Chinese medicine (CM). Ten healthy subjects were considered as the control group. Cytokine levels of interleukin (IL)-17, IL-23 and IL-6 in serum were determined by enzyme-linked immunosorbent assay. Expression levels of signal transducer and activator of transcription 3 (STAT3), p38-mitogen-activated protein kinase (MAPK) and STAT6 in the psoriatic lesions were determined using immunohistochemistry (IHC), Western blot, and real-time quantitative reverse transcription polymerase chain reaction, respectively. RESULTS: Production of IL-17, IL-23 and IL-6 in the BHS group and BSS group were significantly increased compared with those in the control group (P<0.05). Levels of IL-17 and IL-23 in the BHS group were higher than those in the BSS group (P<0.05). Compared with the control group, IHC positive expressions and protein expressions of STAT3 and p38-MAPK, and the STAT3 mRNA expressions in the BHS and BSS groups were significantly higher (P<0.05 or P<0.01). The protein expression of STAT3 in the BHS group was significantly higher than that in the BSS group (P<0.05). CONCLUSIONS: Cytokines in serum and signal transducers in the psoriatic lesions alter with various CM syndromes of psoriasis. The results provide scientific basis for the treatment based on syndrome differentiation of CM in treating psoriasis vulgaris.
Authors: Kristian Otkjaer; Knud Kragballe; Claus Johansen; Anne T Funding; Helle Just; Uffe B Jensen; Lotte G Sørensen; Peder L Nørby; Jes T Clausen; Lars Iversen Journal: J Invest Dermatol Date: 2007-01-25 Impact factor: 8.551
Authors: Ying Luo; Yi Ru; Xiaoying Sun; Yaqiong Zhou; Yingyao Yang; Tian Ma; Rong Xu; Jie Chen; Mi Zhou; Kan Ze; Li Ju; Yanjiao Wang; Qingfeng Yin; Ruiping Wang; Bin Li; Xin Li Journal: Ann Transl Med Date: 2019-11
Authors: Yi Ru; Xiao-Ning Yan; Su-Qing Yang; Li-Ping Gong; Ling-E Li; Jie Chen; Yi-Ding Zhao; Yue-Peng An; Gang Huang; Jin-Fang Zhang; Qing-Feng Yin; Rui-Ping Wang; Xin Li; Bin Li Journal: Ann Transl Med Date: 2019-09
Authors: Xin Li; Qing-Qing Xiao; Fu-Lun Li; Rong Xu; Bin Fan; Min-Feng Wu; Min Zhou; Su Li; Jie Chen; Shi-Guang Peng; Bin Li Journal: Evid Based Complement Alternat Med Date: 2016-05-04 Impact factor: 2.629
Authors: Sang Won Yeon; Su Ryeon Choi; Qing Liu; Yang Hee Jo; Da Hee Choi; Mi Ran Kim; Se Hwan Ryu; Solip Lee; Bang Yeon Hwang; Hyung Seo Hwang; Mi Kyeong Lee Journal: Pharmaceuticals (Basel) Date: 2022-07-27